0%

Archive for the ‘Regulatory & Government’ Category

Although only April is officially considered to be National Minority Health Awareness Month, inequities in health and wellbeing affect minority communities in America every day. This month is dedicated to encouraging greater awareness about health inequities in the United States that specifically affect people of color. The breakthrough: About 30 years ago, the United States […]

Apr 19, 2016

0

Rising costs of prescription drugs are starting to be a hot-button issue for the upcoming 2016 presidential election. The most outspoken candidates on the issue thus far have been Democrats Bernie Sanders and Hilary Clinton. This month, Mr. Sanders introduced a bill in Congress outlining an array of policy changes that would ultimately drive down drug […]

Sep 23, 2015

0

In 2000, the United Nations released 8 Millennium Development Goals outlining ambitions for global change in areas including poverty, gender equality, healthcare and reducing child mortality. These goals were set to be achieved in 15 years. Now that 2015 is nearing an end, the UN is set to embark on a new set of goals […]

Sep 22, 2015

0

Kim Kardashian update! (It’s not often you get to hear that on a clinical trials blog.) After receiving an FDA warning letter about her promotional post for the morning sickness pill Diclegis, the reality star posted a correction on her Instagram account last Sunday. “I guess you saw the attention my last #morningsickness post received,” […]

Sep 01, 2015

0

Flibanserin, widely known as “Female Viagra,” received FDA approval Tuesday night. Manufactured by Sprout Pharmaceuticals, the new drug aims to revive libido in women with hypoactive sexual desire disorder (HSDD). The medication has generated a lot of controversy. Before Tuesday, the FDA had rejected flibanserin twice, in 2010 and 2013, citing “modest” therapeutic benefits and […]

Aug 19, 2015

0

If you are social media user, it is likely you have come across celebrities endorsing their “favorite” products on Facebook, Instagram, and Twitter. You see them raving about their favorite teeth whitening products, juice cleansings, and waist trimmers. But now they are crossing into a new territory: pharmaceuticals. Take for instance, Kim Kardashian. She recently […]

Aug 14, 2015

0

Reforms in the Chinese healthcare system may be to blame for a drop in multinationals’ second-quarter earnings, experts report. Some China-watchers claim this could indicate a “new normal” in one of the world’s fastest expanding pharmaceutical markets. The government has kicked-off a series of reforms aimed at improving the quality and affordability of certain drugs […]

Aug 11, 2015

0

Last month, the 21st Century Cures Act passed the House 344 to 77. The bill will now move to the Senate, where Congress-watchers warn it could face an uphill battle. So what would the bill do, exactly? Here’s a quick breakdown: Improve data-sharing across biopharma To encourage cooperation among clinical researchers, the bill removes regulatory […]

Aug 10, 2015

0

With the announcement of the recent Iranian nuclear deal, business leaders around the world are pondering the consequences and opportunities that relaxing international sanctions could bring. However, current sanctions contain several key exceptions for pharmaceutical products, and drug makers have been allowed to sell in Iran for years. In 2001, a law permitted U.S. companies to obtain specific […]

Jul 16, 2015

0

Too busy to shoot us an email? Let us email you instead!​

pattern
https://clin-edge.com/wp-content/themes/yunik/
https://clin-edge.com/
#4bbde2
style2
default
Loading posts...
#ffffff
on
none
loading
#ffffff
Sort Gallery
https://clin-edge.com/wp-content/themes/yunik
on
no
yes
off
off
off
off